Alphatec Holdings, Inc. (ATEC)
USD 10.21
(-2.3%)
USD 10.21
(-2.3%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -110.59 Million USD | 19.84% |
| 2022 | -102.57 Million USD | -5.17% |
| 2021 | -106.88 Million USD | -131.47% |
| 2020 | -54.84 Million USD | -54.63% |
| 2019 | -48.63 Million USD | -52.47% |
| 2018 | -13.2 Million USD | -6213.44% |
| 2017 | 136 Thousand USD | 97.07% |
| 2016 | -13.2 Million USD | -367.67% |
| 2015 | -149.36 Million USD | -130.67% |
| 2014 | 20.2 Million USD | 155.66% |
| 2013 | -48.81 Million USD | -170.27% |
| 2012 | 10.37 Million USD | -626.81% |
| 2011 | -3.78 Million USD | 91.57% |
| 2010 | 6.7 Million USD | -148.02% |
| 2009 | 2.38 Million USD | 85.77% |
| 2008 | -18.21 Million USD | -335.44% |
| 2007 | -8.27 Million USD | 185.4% |
| 2006 | -13.09 Million USD | 2.54% |
| 2005 | -11.5 Million USD | -15829.41% |
| 2004 | 1.55 Million USD | -99.34% |
| 2003 | 10.89 Million USD | 1464.76% |
| 2002 | -798 Thousand USD | -387.87% |
| 2001 | 277.21 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -19.32 Million USD | 12.63% |
| 2024 Q3 | -88.44 Million USD | 20.75% |
| 2024 Q2 | -12 Million USD | 42.07% |
| 2023 FY | - USD | 19.84% |
| 2023 Q2 | -24.15 Million USD | 27.65% |
| 2023 Q3 | -19.53 Million USD | 19.13% |
| 2023 Q4 | -18.07 Million USD | 7.49% |
| 2023 Q1 | -33.39 Million USD | -41.34% |
| 2022 Q2 | -19.64 Million USD | 12.16% |
| 2022 Q4 | -23.62 Million USD | -16.22% |
| 2022 FY | - USD | -5.17% |
| 2022 Q1 | -22.35 Million USD | 27.86% |
| 2022 Q3 | -20.32 Million USD | -3.49% |
| 2021 Q2 | -21.18 Million USD | -83.29% |
| 2021 Q4 | -30.99 Million USD | -29.01% |
| 2021 FY | - USD | -131.47% |
| 2021 Q1 | -11.55 Million USD | 15.57% |
| 2021 Q3 | -24.02 Million USD | -13.41% |
| 2020 Q2 | -7.16 Million USD | -466.4% |
| 2020 Q3 | -8.21 Million USD | -14.63% |
| 2020 FY | - USD | -54.63% |
| 2020 Q4 | -13.68 Million USD | -66.67% |
| 2020 Q1 | -1.26 Million USD | 79.2% |
| 2019 Q3 | -10.21 Million USD | -30.29% |
| 2019 Q2 | -7.84 Million USD | -130.78% |
| 2019 Q1 | -3.39 Million USD | 36.38% |
| 2019 FY | - USD | -52.47% |
| 2019 Q4 | -6.08 Million USD | 40.46% |
| 2018 Q3 | -5.7 Million USD | -16.51% |
| 2018 Q4 | -5.34 Million USD | 6.45% |
| 2018 FY | - USD | -6213.44% |
| 2018 Q1 | -2.94 Million USD | -99.12% |
| 2018 Q2 | -4.9 Million USD | -66.27% |
| 2017 Q4 | -1.48 Million USD | -323.9% |
| 2017 FY | - USD | 97.07% |
| 2017 Q3 | 661 Thousand USD | -18.29% |
| 2017 Q2 | 809 Thousand USD | 374.24% |
| 2017 Q1 | -295 Thousand USD | 95.37% |
| 2016 FY | - USD | -367.67% |
| 2016 Q1 | 1.89 Million USD | 148.77% |
| 2016 Q4 | -6.37 Million USD | -434.98% |
| 2016 Q3 | 1.9 Million USD | -29.25% |
| 2016 Q2 | 2.69 Million USD | 41.93% |
| 2015 Q1 | 3.81 Million USD | -6.93% |
| 2015 Q4 | -3.88 Million USD | -134.88% |
| 2015 FY | - USD | -130.67% |
| 2015 Q2 | -1.9 Million USD | -150.05% |
| 2015 Q3 | 11.14 Million USD | 683.87% |
| 2014 Q3 | 5.27 Million USD | -8.59% |
| 2014 FY | - USD | 155.66% |
| 2014 Q4 | 4.09 Million USD | -22.34% |
| 2014 Q1 | 1.31 Million USD | 140.94% |
| 2014 Q2 | 5.77 Million USD | 340.35% |
| 2013 Q4 | -3.2 Million USD | 59.75% |
| 2013 FY | - USD | -170.27% |
| 2013 Q3 | -7.95 Million USD | -354.11% |
| 2013 Q1 | -134 Thousand USD | 93.4% |
| 2013 Q2 | -1.75 Million USD | -1207.46% |
| 2012 Q4 | -2.03 Million USD | -152.6% |
| 2012 Q1 | 5.71 Million USD | 446.63% |
| 2012 Q3 | 3.85 Million USD | 219.03% |
| 2012 FY | - USD | -626.81% |
| 2012 Q2 | -3.24 Million USD | -156.72% |
| 2011 Q3 | -1.02 Million USD | 62.58% |
| 2011 FY | - USD | 91.57% |
| 2011 Q4 | -1.64 Million USD | -60.25% |
| 2011 Q2 | -2.75 Million USD | -184.77% |
| 2011 Q1 | 3.24 Million USD | 3664.84% |
| 2010 Q1 | 1.26 Million USD | -64.24% |
| 2010 FY | - USD | -148.02% |
| 2010 Q2 | -1.69 Million USD | -233.36% |
| 2010 Q4 | -91 Thousand USD | -102.01% |
| 2010 Q3 | 4.52 Million USD | 367.77% |
| 2009 Q4 | 3.54 Million USD | 38.57% |
| 2009 Q2 | -958 Thousand USD | -219.6% |
| 2009 Q1 | 801 Thousand USD | 105.56% |
| 2009 FY | - USD | 85.77% |
| 2009 Q3 | 2.55 Million USD | 367.12% |
| 2008 Q2 | -1.64 Million USD | -335.81% |
| 2008 FY | - USD | -335.44% |
| 2008 Q4 | -14.41 Million USD | -3060.57% |
| 2008 Q1 | -377 Thousand USD | -103.6% |
| 2008 Q3 | 487 Thousand USD | 129.64% |
| 2007 FY | - USD | 185.4% |
| 2007 Q2 | 1.97 Million USD | 777.74% |
| 2007 Q3 | -2.68 Million USD | -235.73% |
| 2007 Q4 | 10.47 Million USD | 489.87% |
| 2007 Q1 | -292 Thousand USD | 94.88% |
| 2006 FY | - USD | 2.54% |
| 2006 Q4 | -5.7 Million USD | -57.11% |
| 2006 Q1 | -1.7 Million USD | 96.25% |
| 2006 Q2 | -2.11 Million USD | -24.03% |
| 2006 Q3 | -3.63 Million USD | -71.39% |
| 2005 Q2 | 11.8 Million USD | 71.1% |
| 2005 Q4 | -45.56 Million USD | -485.85% |
| 2005 Q1 | 6.9 Million USD | 152.33% |
| 2005 Q3 | 11.8 Million USD | 0.0% |
| 2005 FY | - USD | -15829.41% |
| 2004 Q3 | 4.45 Million USD | 0.0% |
| 2004 Q1 | 4.45 Million USD | 0.0% |
| 2004 Q2 | 4.45 Million USD | 0.0% |
| 2004 Q4 | -13.18 Million USD | -396.01% |
| 2004 FY | - USD | -99.34% |
| 2003 FY | - USD | 1464.76% |
| 2002 FY | - USD | -387.87% |
| 2001 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -719.99% |
| Cerus Corporation | -26.53 Million USD | -316.762% |
| OrthoPediatrics Corp. | -8.38 Million USD | -1219.556% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -953.81% |
| Talis Biomedical Corporation | -66.04 Million USD | -67.449% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -563.22% |
| Inogen, Inc. | -45.67 Million USD | -142.107% |
| Spectral AI, Inc. | -12.26 Million USD | -801.908% |
| Nano-X Imaging Ltd. | -47.69 Million USD | -131.883% |
| CVRx, Inc. | -38.73 Million USD | -185.539% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -3034.694% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -813.455% |
| Orthofix Medical Inc. | -86.98 Million USD | -27.139% |
| Venus Concept Inc. | -26.11 Million USD | -323.513% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | -122.202% |
| Bioventus Inc. | -23.07 Million USD | -379.376% |
| BrainsWay Ltd. | -2.31 Million USD | -4685.461% |
| Envoy Medical, Inc. | -18.23 Million USD | -506.382% |
| electroCore, Inc. | -17.76 Million USD | -522.703% |
| IceCure Medical Ltd | -15.25 Million USD | -625.051% |
| Lucid Diagnostics Inc. | -49.75 Million USD | -122.291% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -556.111% |
| MaxCyte, Inc. | -44.12 Million USD | -150.616% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -840.729% |
| Nexalin Technology, Inc. | -5.69 Million USD | -1842.923% |
| PAVmed Inc | -75.74 Million USD | -46.011% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | -105.722% |
| RxSight, Inc. | -41.03 Million USD | -169.493% |
| Sight Sciences, Inc. | -49.41 Million USD | -123.802% |
| SI-BONE, Inc. | -34.44 Million USD | -221.059% |
| TELA Bio, Inc. | -40.63 Million USD | -172.173% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | -89.701% |
| Treace Medical Concepts, Inc. | -39 Million USD | -183.511% |
| LivaNova PLC | 39.01 Million USD | 383.453% |
| 908 Devices Inc. | -34.02 Million USD | -225.032% |
| Nemaura Medical Inc. | -7.28 Million USD | -1417.65% |
| NeuroPace, Inc. | -22.83 Million USD | -384.33% |
| LENSAR, Inc. | -8.71 Million USD | -1169.13% |
| Apyx Medical Corporation | -18.11 Million USD | -510.601% |
| Cutera, Inc. | -136.56 Million USD | 19.016% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -3171.953% |
| BioSig Technologies, Inc. | -28.15 Million USD | -292.853% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 4495.548% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -426.905% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 128.832% |
| Axonics, Inc. | 7.77 Million USD | 1522.405% |
| Outset Medical, Inc. | -153.78 Million USD | 28.088% |
| IRIDEX Corporation | -7.44 Million USD | -1384.855% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | -12.74% |
| IRadimed Corporation | 20.8 Million USD | 631.676% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -1271.769% |
| INVO Bioscience, Inc. | -6.88 Million USD | -1507.436% |
| Telesis Bio, Inc. | -40.49 Million USD | -173.114% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 401.53% |
| Varex Imaging Corporation | 67.2 Million USD | 264.571% |
| Quipt Home Medical Corp. | 44.07 Million USD | 350.941% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -917.406% |
| Pulmonx Corporation | -55.09 Million USD | -100.741% |
| Dynatronics Corporation | -976 Thousand USD | -11231.055% |
| Modular Medical, Inc. | -17.1 Million USD | -546.623% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -663.493% |
| Semler Scientific, Inc. | 23.58 Million USD | 568.829% |
| InMode Ltd. | 196.28 Million USD | 156.343% |
| Bruker Corporation | 599 Million USD | 118.463% |
| Cytosorbents Corporation | -28.81 Million USD | -283.856% |
| DexCom, Inc. | 916.7 Million USD | 112.064% |
| Align Technology, Inc. | 799.03 Million USD | 113.841% |
| Viveve Medical, Inc. | -20.61 Million USD | -436.412% |
| ZimVie Inc. | 91.07 Million USD | 221.432% |
| Movano Inc. | -29.12 Million USD | -279.715% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -2408.893% |
| Nexalin Technology, Inc. | -5.69 Million USD | -1842.923% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -3034.694% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 43.186% |
| Profound Medical Corp. | -27.12 Million USD | -307.736% |
| Insulet Corporation | 323.6 Million USD | 134.176% |
| enVVeno Medical Corporation | -25.01 Million USD | -342.05% |
| Surmodics, Inc. | 1.18 Million USD | 9409.091% |
| iCAD, Inc. | -6.56 Million USD | -1584.57% |
| Nuwellis, Inc. | -16.35 Million USD | -576.156% |
| Biotricity, Inc. | -8.82 Million USD | -1152.703% |
| iRhythm Technologies, Inc. | -96.86 Million USD | -14.175% |
| Aethlon Medical, Inc. | -11.84 Million USD | -833.335% |
| InspireMD, Inc. | -20.91 Million USD | -428.87% |
| PAVmed Inc. | -75.74 Million USD | -46.011% |
| BIOLASE, Inc. | -15.13 Million USD | -630.511% |
| Beyond Air, Inc. | -59.03 Million USD | -87.346% |
| FONAR Corporation | 28.25 Million USD | 491.454% |
| AxoGen, Inc. | -13.32 Million USD | -729.772% |
| Vivani Medical, Inc. | -26.6 Million USD | -315.634% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 550.642% |
| Inari Medical, Inc. | 7.11 Million USD | 1654.787% |
| UFP Technologies, Inc. | 72.74 Million USD | 252.031% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -3166.361% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -1696.493% |
| Tenon Medical, Inc. | -15.52 Million USD | -612.21% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -624.433% |
| Co-Diagnostics, Inc. | -41.47 Million USD | -166.642% |
| AdaptHealth Corp. | -171.09 Million USD | 35.361% |
| Sintx Technologies, Inc. | -6.6 Million USD | -1575.636% |
| NanoVibronix, Inc. | -3.43 Million USD | -3119.563% |
| Quanterix Corporation | -38.08 Million USD | -190.359% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -917.406% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 368740.0% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 60.116% |
| TransMedics Group, Inc. | -7.6 Million USD | -1354.584% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -408.119% |
| NeuroMetrix, Inc. | -7.09 Million USD | -1458.554% |
| Hyperfine, Inc. | -47.06 Million USD | -134.997% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | -89.672% |
| Biomerica, Inc. | -5.99 Million USD | -1745.353% |
| Bone Biologics Corporation | 479.57 Thousand USD | 23160.562% |
| AVITA Medical, Inc. | -39.56 Million USD | -179.5% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -1105.634% |
| Silk Road Medical, Inc | -45.08 Million USD | -145.324% |